Actinomyces gerencseriae is a Gram-positive, anaerobic bacterium that belongs to the Actinomyces genus. While Actinomyces species are commonly found in the oral cavity and gastrointestinal tract, Actinomyces gerencseriae is specifically associated with human clinical infections. It has been implicated in a variety of infections, including cervicofacial actinomycosis, an infection that primarily affects the head and neck regions. Cervicofacial actinomycosis caused by Actinomyces gerencseriae typically presents as slowly progressing, indurated abscesses or masses, often with draining sinuses. The infection is characterized by the formation of sulfur granules, which are microscopic colonies of the bacterium. Diagnosis involves clinical evaluation, imaging studies, and often, microscopic examination of purulent material. Treatment of Actinomyces gerencseriae infections typically requires a prolonged course of antibiotics, such as penicillin or amoxicillin. Surgical drainage or excision of abscesses may be necessary in some cases. The prognosis is generally favorable with appropriate and timely intervention, but delays in diagnosis and treatment can lead to chronic, debilitating disease.
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation